• HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity
  • Rhesus D (Rh D), Typing
  • Glucose-6-Phosphate Dehydrogenase (G6PD)
  • Helicobacter pylori Culture with Antimicrobial Susceptibilities
  • Human Immunodeficiency Virus 1 (HIV-1) RNA, Qualitative or Quantitative
  • Cardiac Fibrinogen, Plasma
  • RET/PTC Gene Rearrangement, Molecular
  • Biotinidase Deficiency, Gene Analysis
  • X-Linked Adrenoleukodystrophy (ABCD1) Gene Mutation Analysis, Blood
  • Products of Conception, Ploidy by Flow Cytometry
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Methodology
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.
Loading...